Total Payments
$7,111
2024 Payments
$983.46
Companies
37
Transactions
391
Medicare Patients
6,876
Medicare Billing
$914,632
Payment Breakdown by Category
Food & Beverage$7,089 (99.7%)
Education$22.11 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,089 | 390 | 99.7% |
| Education | $22.11 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,972 | 161 | $0 (2024) |
| Janssen Biotech, Inc. | $778.96 | 57 | $0 (2024) |
| Boston Scientific Corporation | $442.85 | 7 | $0 (2024) |
| PFIZER INC. | $406.56 | 26 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $311.58 | 24 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $293.44 | 16 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $205.22 | 11 | $0 (2024) |
| GENZYME CORPORATION | $177.37 | 6 | $0 (2024) |
| QOL Medical, LLC | $153.08 | 8 | $0 (2024) |
| Celgene Corporation | $138.58 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $983.46 | 44 | ABBVIE INC. ($321.92) |
| 2023 | $1,131 | 61 | ABBVIE INC. ($393.68) |
| 2022 | $1,265 | 59 | ABBVIE INC. ($758.12) |
| 2021 | $998.96 | 49 | AbbVie Inc. ($451.65) |
| 2020 | $341.62 | 20 | AbbVie Inc. ($176.31) |
| 2019 | $814.05 | 46 | AbbVie, Inc. ($234.87) |
| 2018 | $1,003 | 70 | AbbVie, Inc. ($374.78) |
| 2017 | $574.05 | 42 | AbbVie, Inc. ($260.93) |
All Payment Transactions
391 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Immunology | ||||||
| 11/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: LIVER DISEASE | ||||||
| 11/10/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $90.93 | General |
| Category: Gastrointestinal AI | ||||||
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $6.44 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.43 | General |
| Category: Neuroscience | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Immunology | ||||||
| 08/13/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.95 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: General - Biliary Devices_ENDO | ||||||
| 08/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $83.46 | General |
| Category: General - EndoChoice_ENDO | ||||||
| 07/30/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.51 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Hepatology / Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,539 | 1,612 | $1.2M | $206,172 |
| 2022 | 27 | 1,917 | 2,017 | $1.5M | $255,519 |
| 2021 | 24 | 1,724 | 1,819 | $1.2M | $228,296 |
| 2020 | 30 | 1,696 | 1,813 | $1.0M | $224,646 |
Total Patients
6,876
Total Services
7,261
Medicare Billing
$914,632
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 265 | 265 | $294,150 | $58,194 | 19.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 111 | 112 | $90,720 | $21,164 | 23.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 301 | 311 | $152,195 | $19,812 | 13.0% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 77 | 81 | $91,200 | $17,087 | 18.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 166 | 167 | $125,400 | $16,525 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 133 | $75,810 | $12,819 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 154 | $61,600 | $10,033 | 16.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 50 | 51 | $41,310 | $9,524 | 23.1% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $46,550 | $8,856 | 19.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 48 | 57 | $36,515 | $6,546 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $37,230 | $6,483 | 17.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $26,730 | $4,492 | 16.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 56 | 56 | $27,440 | $4,369 | 15.9% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 12 | 13 | $20,540 | $2,581 | 12.6% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 17 | 17 | $13,760 | $2,120 | 15.4% |
| 91010 | Study of esophagus to assess movement | Office | 2023 | 11 | 11 | $10,890 | $2,088 | 19.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 19 | $11,400 | $1,959 | 17.2% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 11 | 11 | $17,050 | $1,117 | 6.6% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 19 | 22 | $2,860 | $404.13 | 14.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 207 | 208 | $230,880 | $44,417 | 19.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 139 | 140 | $113,400 | $27,142 | 23.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 345 | 352 | $145,180 | $21,896 | 15.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 176 | 176 | $130,680 | $20,270 | 15.5% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 85 | 90 | $91,200 | $17,684 | 19.4% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 42 | 45 | $90,450 | $17,297 | 19.1% |
About Dr. Christopher Olenec, MD
Dr. Christopher Olenec, MD is a Gastroenterology healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1891968046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Olenec, MD has received a total of $7,111 in payments from pharmaceutical and medical device companies, with $983.46 received in 2024. These payments were reported across 391 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,089).
As a Medicare-enrolled provider, Olenec has provided services to 6,876 Medicare beneficiaries, totaling 7,261 services with total Medicare billing of $914,632. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Annapolis, MD
- Active Since 04/09/2008
- Last Updated 12/09/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1891968046
Products in Payments
- Humira (Biological) $794.61
- STELARA (Biological) $732.17
- HUMIRA (Biological) $617.88
- RINVOQ (Biological) $547.15
- SKYRIZI (Biological) $533.17
- XELJANZ (Drug) $292.23
- XIFAXAN (Drug) $261.33
- OCALIVA (Drug) $205.22
- DUPIXENT (Biological) $192.02
- LINZESS (Drug) $164.04
- ENTYVIO (Biological) $162.08
- SUCRAID (Drug) $153.08
- ZEPOSIA (Drug) $138.58
- VIBERZI (Drug) $126.62
- ACQUIRE (Device) $118.31
- Cimzia (Drug) $112.31
- CREON (Drug) $102.85
- GI GENIUS (Device) $90.93
- Linzess (Drug) $86.84
- General - GI Dilatation (Device) $81.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Annapolis
Dr. Michael Epstein, M.d, M.D
Gastroenterology — Payments: $644,789
Gastroenterology $644,789
Dr. Raja Taunk, M.d, M.D
Gastroenterology — Payments: $347,396
Gastroenterology $347,396
Dr. Mark Flasar, M.d, M.D
Gastroenterology — Payments: $155,798
Gastroenterology $155,798
Dr. Kevin Wolov, D.o, D.O
Gastroenterology — Payments: $31,103
Gastroenterology $31,103
Dr. Vishnupriya Krishna, Md, MD
Gastroenterology — Payments: $17,302
Gastroenterology $17,302
Dr. Charles King, M.d, M.D
Gastroenterology — Payments: $7,579
Gastroenterology $7,579